Study finds new, promising target for IBD treatment
New research suggests there is a way to optimize treatments for inflammatory bowel disease, or IBD.
IBD
Glial cell discovery could open door to new treatments for IBD
Researchers found that glial cells coordinate immune responses of the gut following pathogen invasion or insult to the tissues.
Environmentally-friendly method for creating a ‘high demand’ ingredient in IBD treatments
For creating a small-molecule drug, researchers developed a large-scale synthesis method for easily developing a compound necessary for IBD treatment.
Intestinal memory discovered: Immune cells ‘trained’ to ‘remember’ diseases for future protection
Scientists at the Institut Pasteur discovered innate effector cells active in early infection that can also be trained to “remember” that disease and protect the host from reinfection.
Animal study uncovers molecular mechanism behind colon pain, inflammation
A recent mouse study suggests a reason behind colitis is the activation of a receptor that promotes inflammation and pain.
Scientists create ‘snapshot’ of how gut microbiome communicates with immune cells; could lead to IBD treatment
People with IBD have shown a reduced diversity in their gut microbiome with notable decreases among Bacteroides and Firmicutes bacteria.
Opioids show promise as effective treatment for gut inflammation, IBD symptoms
Study results point to a promising future for opioids when it comes to treatment of inflammatory bowel disease and other gut ailments.
Researchers find one potential driver of childhood IBD
New research suggests small proteins called IL-36 cytokines may be a critical target for treating childhood inflammatory bowel disease (IBD).
IBD cure on horizon? Poop study identifies key protein that causes ulcerative colitis
A group of microbial enzymes living in the gut microbiome were found to be the culprit behind ulcerative colitis.
Gradual changes in proteins protect modern-day people from forms of oxidative stress
Swedish and German researchers find that a modern biological change to a protein in the human body protects individuals from oxidative stress that causes vascular diseases and inflammatory bowel disease (IBS).